Vincerx Pharma Inc. (VINC)

Business: Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States.

IPO Date: 27-May-2020

Founder, Chairman & CEO: Dr. Ahmed M. Hamdy M.D.

Founder, Gen. Counsel & Chief Legal Officer: Mr. Tom C. Thomas J.D.

Listing: NASDAQ: VINC

Country: United States

Headquarters: Palo Alto, CA

Website: https://vincerx.com

Market cap: $27.80 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-49.45 Mln

Cash: $96.49 Mln

Total Debt: $0.85 Mln

Insider's Holding: 28.65%

Liquidity: Low

52 Week range: $1.27 - 18.43

Shares outstanding: 21,057,600